Immediate Impact

54 standout
Sub-graph 1 of 22

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
5 intermediate papers

Works of Karin Kaasjager being referenced

Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
2020

Author Peers

Author Last Decade Papers Cites
Karin Kaasjager 351 75 324 119 10 758
Wilhelmina G. Melsen 255 9 285 196 6 883
Andrea Azzola 246 25 188 319 23 755
Laurie G. Jacobs 153 88 68 46 39 773
Jeremiah J. Duby 89 20 165 57 31 976
Pawan Sikka 344 5 188 270 8 779
Roman Z. Jaeschke 103 70 132 113 7 914
Ronald J. Manning 224 27 288 201 16 874
Edith Bauer 301 16 121 88 16 700
Louis D. Gottlieb 119 32 103 33 11 833
Alfred F.A.M. Schobben 122 17 31 76 19 934

All Works

Loading papers...

Rankless by CCL
2026